Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
ranibizumab | vascular endothelial growth factor a | biotech | Successful target | TTD , drugbank , DGIDB | Age related macular degeneration[MeSHID:D008268] Retinal Vein Occlusion[MeSHID:D012170] Macular Edema Cystoid[MeSHID:D008269] Macular Degeneration Age-Related 2[MeSHID:C562479] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hereditary hemorrhagic telangiectasia[MeSHID:D013683] |
8.79 | approved | inhibitor |
ranibizumab | vascular endothelial growth factor a | biotech | Successful target | TTD , drugbank , DGIDB | Age related macular degeneration[MeSHID:D008268] Retinal Vein Occlusion[MeSHID:D012170] Macular Edema Cystoid[MeSHID:D008269] Macular Degeneration Age-Related 2[MeSHID:C562479] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hereditary hemorrhagic telangiectasia[MeSHID:D013683] |
8.79 | approved | unknown |
click here to return to the previous page |